a unified approach to higher risk mds: standard and emerging therapies
Published 7 years ago • 185 plays • Length 22:08Download video MP4
Download video MP3
Similar videos
-
21:55
a unified approach to lower risk mds: standard and emerging therapies
-
24:04
my approach to mds management
-
2:50
how is higher-risk mds treated?
-
19:12
an approach to diagnosis and staging of mds: from morphology to genetics
-
58:22
myelodysplastic syndromes: key take-home messages from eha and asco 2024
-
55:37
who classification of myelodysplastic syndromes
-
10:20
myelodysplastic syndrome – causes, types, signs and symptoms, diagnosis & treatment
-
6:33
myelodysplastic syndromes - causes, symptoms, diagnosis, treatment, pathology
-
1:13:29
understanding higher risk mds and transtion to aml
-
18:42
case discussion: high-risk myelodysplastic syndromes
-
4:28
understanding myelodysplastic syndromes (mds)
-
20:03
my approach to mf management
-
3:31
promising treatment options emerging for higher-risk mds & the value of clinical trials
-
22:13
how to approach hma failure?
-
22:41
new opportunities in experimental therapeutics in mds
-
3:08
the treatment protocol for higher risk mds
-
2:21
precision medicine for mds, what drugs for which patients?
-
17:29
somatic mutations of rna splicing machinery in mds
-
4:42
a practical approach to the classification of mds
-
1:58
what are the challenges to mutation-driven mds treatment?
-
2:28
immunosuppressive therapy in myelodysplastic syndrome